Investigation of Bleeding Disorders: When and How Should We Test Platelet Functions?

Abstract

Introduction

Inherited platelet disorders (IPDs) are rare conditions with diverse underlying pathophysiology which should be suspected in patients presenting with mucocutaneous bleeding or hemorrhages upon hemostatic challenges, in the presence or not of thrombocytopenia. Identifying IPDs is critical for providing appropriate care, preventing misdiagnosis, and avoiding unnecessary interventions, such as splenectomy. Syndromic IPDs, which may be associated with severe complications like kidney failure, infection, and malignancies, underscore the importance of accurate diagnosis and tailored management.

Results

Diagnosing IPDs remains challenging, requiring a comprehensive approach that integrates clinical assessment, evaluation of the bleeding history using standardized tools, like the ISTH-BAT, and first-line laboratory tests, such as light transmission aggregometry and flow cytometry. Second-line and specialized tests, including transmission electron microscopy, genetic analysis, and biochemical studies, may provide further insight in complex cases. Technological advancements, including multicolor flow cytometry and microfluidic tools, may in perspective improve IPD diagnostics by providing high-throughput and precise laboratory assays. In particular, mass cytometry and multi-omics may contribute to unraveling IPD pathophysiology, identifying novel markers, and refining disease classification. The application of artificial intelligence shows potential for improving diagnostic accuracy through the automated analysis of platelet morphology and function, from flow cytometry and digital microscopy assays, and for improving the understanding of pathogenic mechanisms of IPD through the examination of big data.

Conclusion

This review summarizes current IPD platelet function testing strategies, emphasizing the need for a structured, tiered approach and examining emerging technologies and AI applications that could revolutionize diagnostic workflows, leading to personalized care and to an expanded understanding of IPDs.

Keywords

flow cytometry - inherited platelet function disorders - light transmission aggregometry

Publikationsverlauf

Eingereicht: 04. November 2024

Angenommen: 09. Februar 2025

Artikel online veröffentlicht:
12. Mai 2025

• References

• 1 Palma-Barqueros V, Revilla N, Sánchez A. et al. Inherited platelet disorders: an updated overview. Int J Mol Sci 2021; 22 (09) 4521
• 2 Quiroga T, Goycoolea M, Panes O. et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92 (03) 357-365
• 3 Gresele P, Harrison P, Bury L. et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost 2014; 12 (09) 1562-1569
• 4 Oved JH, Lambert MP, Kowalska MA, Poncz M, Karczewski KJ. Population based frequency of naturally occurring loss-of-function variants in genes associated with platelet disorders. J Thromb Haemost 2021; 19 (01) 248-254
• 5 Stefanucci L, Collins J, Sims MC. et al. The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants. Blood 2023; 142 (24) 2055-2068
• 6 Orsini S, Noris P, Bury L. et al; European Hematology Association - Scientific Working Group (EHA-SWG) on Thrombocytopenias and Platelet Function Disorders. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica 2017; 102 (07) 1192-1203
• 7 McKay H, Derome F, Haq MA. et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104 (01) 159-165
• 8 Rodeghiero F, Tosetto A, Abshire T. et al; ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (09) 2063-2065
• 9 Gresele P, Orsini S, Noris P. et al; BAT-VAL Study Investigators. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC. J Thromb Haemost 2020; 18 (03) 732-739
• 10 Gresele P, Falcinelli E, Bury L. et al; BAT-VAL Study Investigators. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost 2021; 19 (05) 1364-1371
• 11 Gresele P, Falcinelli E, Bury L. et al. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assessment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC. Res Pract Thromb Haemost 2023; 8 (01) 102305
• 12 Gresele P, Bury L, Falcinelli E. Inherited platelet function disorders: algorithms for phenotypic and genetic investigation. Semin Thromb Hemost 2016; 42 (03) 292-305
• 13 Konkle BA. Acquired disorders of platelet function. Hematology (Am Soc Hematol Educ Program) 2011; 2011: 391-396
• 14 Gresele P, Falcinelli E, Bury L. Inherited platelet function disorders. Diagnostic approach and management. Hamostaseologie 2016; 36 (04) 265-278
• 15 Bury L, Falcinelli E, Gresele P. Learning the ropes of platelet count regulation: inherited thrombocytopenias. J Clin Med 2021; 10 (03) 533
• 16 Reese JA, Peck JD, Deschamps DR. et al. Platelet counts during pregnancy. N Engl J Med 2018; 379 (01) 32-43
• 17 Balduini CL, Cattaneo M, Fabris F. et al; Italian Gruppo di Studio delle Piastrine. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 2003; 88 (05) 582-592
• 18 Noris P, Biino G, Pecci A. et al. Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood 2014; 124 (06) e4-e10
• 19 Zaninetti C, Santini V, Tiniakou M, Barozzi S, Savoia A, Pecci A. Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases. J Thromb Haemost 2017; 15 (12) 2388-2392
• 20 Gresele P. , Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13 (02) 314-322
• 21 Pontara E, Gresele P, Cattini MG. et al. Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. Blood Coagul Fibrinolysis 2014; 25 (04) 401-404
• 22 Downes K, Megy K, Duarte D. et al; NIHR BioResource. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood 2019; 134 (23) 2082-2091
• 23 Podda GM, Pugliano M, Femia EA. et al. The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories. Am J Hematol 2012; 87 (07) 727-728
• 24 Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med 2012; 50 (08) 1281-1285
• 25 Cohen AM, Cycowitz Z, Mittelman M, Lewinski UH, Gardyn J. The incidence of pseudothrombocytopenia in automatic blood analyzers. Haematologia (Budap) 2000; 30 (02) 117-121
• 26 Sánchez Guiu IM, Martínez-Martinez I, Martínez C. et al. An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets. Thromb Haemost 2015; 114 (02) 313-324
• 27 Crome PE, Barkhan P. Platelet adherence to polymorphs. BMJ 1963; 2 (5361) 871
• 28 Noris P, Klersy C, Zecca M. et al. Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. J Thromb Haemost 2009; 7 (12) 2131-2136
• 29 Lau C, Gonçalves M, Pereira M, Monteiro C, Morais S, Lima M. Platelet forward scatter index: usefulness to evaluate the platelet size and to discriminate subtypes of inherited thrombocytopenias. Int J Lab Hematol 2022; 44 (05) e208-e210
• 30 Ferreira FLB, Colella MP, Medina SS. et al. Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias. Sci Rep 2017; 7 (01) 3355
• 31 Miyazaki K, Koike Y, Kunishima S. et al. Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Hematology 2015; 20 (10) 587-592
• 32 Cattaneo M, Cerletti C, Harrison P. et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. . J Thromb Haemost 2013
• 33 Althaus K, Zieger B, Bakchoul T, Jurk K. THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) und der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Standardization of light transmission aggregometry for diagnosis of platelet disorders: an inter-laboratory external quality assessment. Thromb Haemost 2019; 119 (07) 1154-1161
• 34 Stépanian A, Fischer F, Flaujac C. et al. Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditation. Platelets 2024; 35 (01) 2427745
• 35 De Candia E, Pecci A, Ciabattoni G. et al. Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. J Thromb Haemost 2007; 5 (03) 551-559
• 36 Nieswandt B, Brakebusch C, Bergmeier W. et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20 (09) 2120-2130
• 37 Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J 1995; 306 (Pt 2): 337-344
• 38 Sandrock K, Zieger B. Current strategies in diagnosis of inherited storage pool defects. Transfus Med Hemother 2010; 37 (05) 248-258
• 39 Palma-Barqueros V, Crescente M, de la Morena ME. et al. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis. Am J Hematol 2021; 96 (03) E83-E88
• 40 Palma-Barqueros V, Bohdan N, Revilla N, Vicente V, Bastida JM, Rivera J. PTGS1 gene variations associated with bleeding and platelet dysfunction. Platelets 2021; 32 (05) 710-716
• 41 Lin TM, Lin JS, Tseng JY, Wu SY, Chen TY. Impaired responsiveness of platelets to epinephrine due to α2A adrenoreceptor deficiency in male Chinese. Platelets 2016; 27 (02) 149-154
• 42 Qayyum R, Becker LC, Becker DM. et al. Genome-wide association study of platelet aggregation in African Americans. BMC Genet 2015; 16: 58
• 43 Hayward CP, Rivard GE, Kane WH. et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996; 87 (12) 4967-4978
• 44 Ghosh K, Nair S, Kulkarni B, Khare A, Shetty S, Mohanty D. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function. Platelets 2003; 14 (06) 351-354
• 45 Platton S, McCormick Á, Bukht M, Gurney D, Holding I, Moore GW. A multicenter study to evaluate automated platelet aggregometry on Sysmex CS-series coagulation analyzers-preliminary findings. Res Pract Thromb Haemost 2018; 2 (04) 778-789
• 46 Le Blanc J, Mullier F, Vayne C, Lordkipanidzé M. Advances in platelet function testing-light transmission aggregometry and beyond. J Clin Med 2020; 9 (08) 2636
• 47 Yoon I, Han JH, Jeon HJ. Advances in platelet-dysfunction diagnostic technologies. Biomolecules 2024; 14 (06) 714
• 48 Lordkipanidzé M, Lowe GC, Kirkby NS. et al; UK Genotyping and Phenotyping of Platelets Study Group. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood 2014; 123 (08) e11-e22
• 49 De Cuyper IM, Meinders M, van de Vijver E. et al. A novel flow cytometry-based platelet aggregation assay. Blood 2013; 121 (10) e70-e80
• 50 van Asten I, Schutgens REG, Baaij M. et al. Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect. J Thromb Haemost 2018; 16 (04) 689-698
• 51 Frelinger III AL, Rivera J, Connor DE. et al. Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost 2021; 19 (12) 3193-3202
• 52 van Asten I, Schutgens REG, Urbanus RT. Toward flow cytometry based platelet function diagnostics. An exhaustive review on flow cytometry in platelet function diagnostics. Semin Thromb Hemost 2018; 44 (03) 197-205
• 53 Giannini S, Mezzasoma AM, Leone M, Gresele P. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Haematologica 2007; 92 (12) 1647-1654
• 54 Giannini S, Cecchetti L, Mezzasoma AM, Gresele P. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica 2010; 95 (06) 1021-1024
• 55 Jourdi G, Ramström S, Sharma R, Bakchoul T, Lordkipanidzé M. FC-PFT in TP Study Group. Consensus report on flow cytometry for platelet function testing in thrombocytopenic patients: communication from the SSC of the ISTH. J Thromb Haemost 2023; 21 (10) 2941-2952
• 56 Mezzano D, Harrison P, Frelinger III AL. et al. Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost 2022; 20 (09) 2127-2135
• 57 Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21 (01) 21-36
• 58 Walz DA. Platelet-released proteins as molecular markers for the activation process. Semin Thromb Hemost 1984; 10 (04) 270-279
• 59 Ohkawa R, Hirowatari Y, Nakamura K. et al. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin Biochem 2005; 38 (11) 1023-1026
• 60 Aranda E, Iha S, Solari S. et al. Serotonin secretion by blood platelets: accuracy of high-performance liquid chromatography-electrochemical technique compared with the isotopic test and use in a clinical laboratory. Res Pract Thromb Haemost 2023; 7 (05) 102156
• 61 van Asten I, Blaauwgeers M, Granneman L. et al. Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency. J Thromb Haemost 2020; 18 (03) 706-713
• 62 Hayward CP, Moffat KA, Spitzer E. et al; NASCOLA Working Group on Platelet Dense Granule Deficiency. Results of an external proficiency testing exercise on platelet dense-granule deficiency testing by whole mount electron microscopy. Am J Clin Pathol 2009; 131 (05) 671-675
• 63 Chen D, Uhl CB, Bryant SC. et al. Diagnostic laboratory standardization and validation of platelet transmission electron microscopy. Platelets 2018; 29 (06) 574-582
• 64 Brunet JG, Iyer JK, Badin MS. et al. Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency. Int J Lab Hematol 2018; 40 (04) 400-407
• 65 Stormorken H, Holmsen H, Sund R. et al. Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality?. Thromb Haemost 1995; 74 (05) 1244-1251
• 66 Halliez M, Fouassier M, Robillard N. et al. Detection of phosphatidyl serine on activated platelets' surface by flow cytometry in whole blood: a simpler test for the diagnosis of Scott syndrome. Br J Haematol 2015; 171 (02) 290-292
• 67 Misceo D, Holmgren A, Louch WE. et al. A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat 2014; 35 (05) 556-564
• 68 Glembotsky AC, Sliwa D, Bluteau D. et al. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia. Haematologica 2019; 104 (06) 1244-1255
• 69 Gresele P, Bury L, Mezzasoma AM, Falcinelli E. Platelet function assays in diagnosis: an update. Expert Rev Hematol 2019; 12 (01) 29-46
• 70 Dupuis A, Bordet JC, Eckly A, Gachet C. Platelet δ-storage pool disease: an update. J Clin Med 2020; 9 (08) 2508
• 71 Favier R, Jondeau K, Boutard P. et al. Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost 2003; 90 (05) 893-897
• 72 Necchi V, Balduini A, Noris P. et al. Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. Thromb Haemost 2013; 109 (02) 263-271
• 73 Greinacher A, Pecci A, Kunishima S. et al. Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost 2017; 15 (07) 1511-1521
• 74 Zaninetti C, Leinøe E, Lozano ML. et al. Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders. J Thromb Haemost 2023; 21 (04) 1010-1019
• 75 Ver Donck F, Downes K, Freson K. Strengths and limitations of high-throughput sequencing for the diagnosis of inherited bleeding and platelet disorders. J Thromb Haemost 2020; 18 (08) 1839-1845
• 76 Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4 (02) 312-319
• 77 Baccolo A, Falcinelli E, Mezzasoma AM. et al. Usefulness of global tests of primary hemostasis in the initial screening of mild/moderate bleeding disorders for orienting towards von Willebrand disease or inherited platelet functions disorders. Thromb Res 2023; 221: 79-82
• 78 Dupuis A, Heim V, Ohlmann P, Gachet C. In vitro binding of [³H]PSB-0413 to P2Y₁₂ receptors. Curr Protocols Pharmacol 2015; 71: 35.1 , 19
• 79 Berrou E, Adam F, Lebret M. et al. Heterogeneity of platelet functional alterations in patients with filamin A mutations. Arterioscler Thromb Vasc Biol 2013; 33 (01) e11-e18
• 80 Rao AK. Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction. Hematol Oncol Clin North Am 2013; 27 (03) 585-611
• 81 Stockley J, Morgan NV, Bem D. et al; UK Genotyping and Phenotyping of Platelets Study Group. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood 2013; 122 (25) 4090-4093
• 82 Kjellberg G, Holm M, Lindvall G, Gryfelt G, van der Linden J, Wikman A. Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion. Transfus Med 2020; 30 (05) 369-376
• 83 Ahammad J, Kamath A, Shastry S, Chitlur M, Kurien A. Clinico-hematological and thromboelastographic profiles in Glanzmann's thrombasthenia. Blood Coagul Fibrinolysis 2020; 31 (01) 29-34
• 84 Shenkman B, Savion N, Dardik R, Tamarin I, Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000; 99 (04) 353-361
• 85 Minami H, Nogami K, Ogiwara K, Furukawa S, Hosokawa K, Shima M. Use of a microchip flow-chamber system as a screening test for platelet storage pool disease. Int J Hematol 2015; 102 (02) 157-162
• 86 Atari B, Ito T, Nagasato T. et al. A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia. Thromb J 2020; 18 (01) 31
• 87 Mansouritorghabeh H, Monard A, Heubel-Moenen F, Leentjens J, Stroobants A, Henskens Y. The utility of total thrombus-formation analysis system (T-TAS) in the thrombosis and hemostasis field: a scoping review. . Int J Lab Hematol 2024
• 88 de Witt SM, Swieringa F, Cavill R. et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun 2014; 5: 4257
• 89 Garcia C, Dejean S, Savy N. et al. Multicolor flow cytometry in clinical samples for platelet signaling assessment. Res Pract Thromb Haemost 2023; 7 (04) 100180
• 90 Johnson B, Lowe GC, Futterer J. et al; UK GAPP Study Group. Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects. Haematologica 2016; 101 (10) 1170-1179
• 91 Hui H, Fuller K, Erber WN, Linden MD. Measurement of monocyte-platelet aggregates by imaging flow cytometry. Cytometry A 2015; 87 (03) 273-278
• 92 Blair TA, Michelson AD, Frelinger III AL. Mass cytometry reveals distinct platelet subtypes in healthy subjects and novel alterations in surface glycoproteins in Glanzmann thrombasthenia. Sci Rep 2018; 8 (01) 10300
• 93 Gresele P. Artificial intelligence and machine learning in hemostasis and thrombosis. Bleeding Thromb Vasc Biol 2023; 2: 105
• 94 Guo P, Zhang C, Liu D, Sun Z, He J, Wang J. Evaluation of artificial intelligence-assisted morphological analysis for platelet count estimation. Int J Lab Hematol 2024; 46 (06) 1012-1020
• 95 Kempster C, Butler G, Kuznecova E. et al. Fully automated platelet differential interference contrast image analysis via deep learning. Sci Rep 2022; 12 (01) 4614
• 96 Zhou Y, Yasumoto A, Lei C. et al. Intelligent classification of platelet aggregates by agonist type. eLife 2020; 9: e52938
• 97 Miah H, Kollias D, Pedone GL, Provan D, Chen F. Can machine learning assist in diagnosis of primary immune thrombocytopenia? A feasibility study. Diagnostics (Basel) 2024; 14 (13) 1352
• 98 Gutmann C, Joshi A, Mayr M. Platelet "-omics" in health and cardiovascular disease. Atherosclerosis 2020; 307: 87-96
• 99 De Wispelaere K, Freson K. The analysis of the human megakaryocyte and platelet coding transcriptome in healthy and diseased subjects. Int J Mol Sci 2022; 23 (14) 7647
• 100 Kreft IC, Huisman EJ, Cnossen MH. et al. Proteomic landscapes of inherited platelet disorders with different etiologies. J Thromb Haemost 2023; 21 (02) 359-372.e3